
LC Top AM 75mg/5mg/10mg Tablet SR
Marketer
Olamic Healthcare
Salt Composition
Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
Overview LC Top AM 75mg/5mg/10mg Tablet SR
Amisulpride/Bromhexine/Guaifenesin extended-release tablets (75mg/5mg/10mg) are a combined formulation indicated for managing respiratory conditions characterized by thick mucus. This medication offers relief from productive coughs associated with ailments such as bronchial asthma, bronchitis, and the common cold. Dosage and duration for Amisulpride/Bromhexine/Guaifenesin 75mg/5mg/10mg ER tablets should strictly follow your physician's instructions, regardless of meal timing. Treatment should continue as prescribed to prevent symptom recurrence and condition exacerbation. Inform your healthcare provider of all concurrent medications, as interactions are possible. Common, generally transient side effects include nausea, indigestion, dry mouth, influenza-like symptoms, tiredness, and headache. Report any concerning side effects immediately. Due to potential drowsiness and dizziness, refrain from activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided as it may intensify drowsiness. Pre-existing liver or kidney conditions, pregnancy, pregnancy planning, or breastfeeding should be disclosed to your doctor prior to commencing treatment to ensure appropriate dosage.
Uses of LC Top AM 75mg/5mg/10mg Tablet SR
Managing respiratory illnesses characterized by thick mucus.
Major Benefits of LC Top AM 75mg/5mg/10mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The LC Top AM 75mg/5mg/10mg sustained-release tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of LC Top AM 75mg/5mg/10mg Tablet SR:
- Nausea
- Upset stomach
- Dryness in mouth
- Headache
- Fatigue
- Allergic reaction
- Sleepiness
- Flu-like symptoms
How to use LC Top AM 75mg/5mg/10mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The LC Top AM 75mg/5mg/10mg sustained-release tablet can be consumed with or without food, though consistent daily timing is recommended.
How LC Top AM 75mg/5mg/10mg Tablet SR works:
Each LC Top AM 75mg/5mg/10mg extended-release tablet combines ambroxol, levocetirizine, and montelukast to address respiratory symptoms. Ambroxol, a mucolytic agent, facilitates mucus clearance by reducing its viscosity. Levocetirizine, an antihistamine, alleviates allergic manifestations such as nasal discharge, ocular itching, and sneezing. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thereby diminishing airway and nasal inflammation and improving overall symptom control.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using alcohol concurrently with LC Top AM 75mg/5mg/10mg SR tablets. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The extended-release combination tablet LC Top AM (75mg/5mg/10mg) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release combination tablet, LC Top AM 75mg/5mg/10mg, is likely unsuitable for breastfeeding mothers. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
The extended-release combination tablet LC Top AM 75mg/5mg/10mg can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use the 75mg/5mg/10mg sustained-release LC Top AM tablet cautiously, as dosage modification may be necessary. Individuals with severe kidney disease should avoid this medication; physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using LC Top AM 75mg/5mg/10mg SR tablets. Dosage modification of LC Top AM 75mg/5mg/10mg SR tablets may be necessary. Physician consultation is recommended.
What if you forget to take LC Top AM 75mg/5mg/10mg Tablet SR :
Should you forget to take your LC Top AM 75mg/5mg/10mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About LC Top AM 75mg/5mg/10mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
